Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Chindex accepted a buy-out offer of $24 per share from...
MicroDiag Biomedicine, a Suzhou maker of cancer...
At last month’s ChinaBio® Partnering Forum, the...
JHL Biotech, a Taiwan-China biopharma that develops...
Change and growth are the watchwords for China's life...
Last week, Johnson & Johnson announced the opening of an...
Sirnaomics, a US-China biopharma, together with its...
Innovent Biologics of Suzhou announced a $100 million C...
Innovent Biologics of Suzhou will collaborate with Lilly...
Shanghai's Genor Biopharma will collaborate with MabSpace...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
